Followers | 12 |
Posts | 355 |
Boards Moderated | 0 |
Alias Born | 09/13/2014 |
Saturday, August 12, 2023 9:24:41 PM
·
Development of a new therapy in the pharma industry faces many unexpected barriers. You would expect that a demonstrated technology that could successfully help 36 million people infected with HIV and that could possibly change the fate of over 1 million who die each year from the virus, would garner support from those in the industry. We have found this is not the case. If a therapy is “not invented here” and there is less than animal or clinical trial evidence (which costs millions of dollars) that removes all possible doubt about its success, very few will be interested. So, the difficulty is not only creating unbelievable technology, but once created, finding a meaningful partner or the huge sums of money needed to independently carry the technology to market.
Recent ENZC News
- Small Cap Recipient of Military Drone Technology • InvestorsHub NewsWire • 11/20/2023 01:14:45 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM